Levisonics

Levisonics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.7M

Overview

Levisonics is a privately-held, pre-revenue medical device company based in Cambridge, Massachusetts, specializing in diagnostic platform development. The company leverages academic research to create tools for precise blood coagulation and rheological analysis, targeting unmet needs in clinical diagnostics and drug delivery. With a small, PhD-heavy leadership team, Levisonics is in the early stages of technology development and validation. Its success hinges on translating its novel measurement platform into a commercially viable product for clinical and research markets.

Hematology

Technology Platform

Novel platform for blood coagulation analysis and fluid rheological measurement, likely based on acoustics, microfluidics, or optical techniques derived from academic research.

Funding History

2
Total raised:$3.7M
Seed$3.2M
Grant$500K

Opportunities

The global coagulation testing market is large and growing, driven by aging populations and new anticoagulant therapies.
A novel, potentially superior platform could capture market share in both clinical diagnostics and biopharma R&D.
The company's academic foundation provides access to cutting-edge research and talent.

Risk Factors

High technical and regulatory risk in translating an academic prototype into an approved medical device.
Intense competition from large, established diagnostics companies with entrenched products and sales channels.
Dependence on external funding as a pre-revenue startup.

Competitive Landscape

The coagulation diagnostics market is dominated by major players like Abbott, Werfen, Roche, and Haemonetics. Competition is based on assay menu, speed, ease-of-use, and integration into clinical workflows. Levisonics must demonstrate clear advantages in performance, cost, or application to overcome high barriers to entry.